Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retention among North American HIV-infected persons in clinical care, 2000-2008.
Rebeiro P, Althoff KN, Buchacz K, Gill J, Horberg M, Krentz H, Moore R, Sterling TR, Brooks JT, Gebo KA, Hogg R, Klein M, Martin J, Mugavero M, Rourke S, Silverberg MJ, Thorne J, Gange SJ; North American AIDS Cohort Collaboration on Research and Design. Rebeiro P, et al. Among authors: buchacz k. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):356-62. doi: 10.1097/QAI.0b013e31827f578a. J Acquir Immune Defic Syndr. 2013. PMID: 23242158 Free PMC article.
Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: implications for vaccine trials.
Buchacz K, Hu DJ, Vanichseni S, Mock PA, Chaowanachan T, Srisuwanvilai LO, Gvetadze R, Van Griensven F, Tappero JW, Kitayaporn D, Kaewkungwal J, Choopanya K, Mastro TD. Buchacz K, et al. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):853-60. doi: 10.1097/00126334-200407010-00013. J Acquir Immune Defic Syndr. 2004. PMID: 15213570
Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study.
Young B, Buchacz K, Baker RK, Moorman AC, Wood KC, Chmiel J, Brooks JT; HIV Outpatient Study Investigators. Young B, et al. Among authors: buchacz k. J Int Assoc Physicians AIDS Care (Chic). 2007 Sep;6(3):178-87. doi: 10.1177/1545109707300676. Epub 2007 Jun 19. J Int Assoc Physicians AIDS Care (Chic). 2007. PMID: 17579126
Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency.
Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Moorman AC, Wood KC, Holmberg SD, Brooks JT; HIV Outpatient Study (HOPS) Investigators. Lichtenstein KA, et al. Among authors: buchacz k. J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):27-35. doi: 10.1097/QAI.0b013e31815acacc. J Acquir Immune Defic Syndr. 2008. PMID: 17971714
181 results